Arrivent BioPharma, Inc. (AVBP)
25.19
+0.22
(+0.88%)
USD |
NASDAQ |
Apr 07, 16:00
25.45
+0.26
(+1.03%)
After-Hours: 04:18
Arrivent BioPharma Total Assets (Quarterly) : 333.17M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocugen, Inc. | 44.29M |
| Bristol Myers Squibb Co. | 90.04B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.94M |
| Shareholders Equity (Quarterly) | 307.22M |
| Current Ratio | 12.83 |
| Net Debt Paydown Yield | 0.00% |